Document is current
Any future updates will be listed below
-
Authors
Breu, Jana
Baumann, Bernhard
Sa, Jason K.
Berghoff, Anna Sophie
Preusser, Matthias
Nenning, Karl-Heinz
Woehrer, Adelheid https://orcid.org/0000-0001-8435-8189
-
Funding
Funding for this research was provided by:
Austrian Science Fund (TAI98-B)
Vienna Science and Technology Fund (LS20-034)
University of Innsbruck and Medical University of Innsbruck
- License Information
-
More Information
Article History
Received: 27 January 2026
Accepted: 19 February 2026
First Online: 10 March 2026
Conflict of interest
: A.S. Berghoff has research support from Daiichi Sankyo, Roche and honoraria for lectures, consultation or advisory board from participation from Roche, Bristol-Myers Squibb, Merck, Daiichi Sankyo, AstraZeneca, CeCaVa, Seagen, Alexion and Servier. M. Preusser has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, AstraZeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Janssen, Servier, Miltenyi, Boehringer-Ingelheim, Telix, Medscape. J. Breu, B. Baumann, J.K. Sa, K.-H. Nenning and A. Woehrer declare that they have no competing interests.
